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Abstract
During epithelial ovarian cancer (EOC) progression, intraperitoneally disseminating tumor cells 
and multi-cellular aggregates (MCAs) present in ascites fluid adhere to the peritoneum and induce 
retraction of the peritoneal mesothelial monolayer prior to invasion of the collagen-rich sub-
mesothelial matrix and proliferation into macro-metastases. Clinical studies have shown 
heterogeneity among EOC metastatic units with respect to cadherin expression profiles and 
invasive behavior, however the impact of distinct cadherin profiles on peritoneal anchoring of 
metastatic lesions remains poorly understood. In the current study, we demonstrate that metastasis-
associated behaviors of ovarian cancer cells and MCAs are influenced by cellular cadherin 
composition. Our results show that mesenchymal N-cadherin expressing (Ncad+) cells and MCAs 
invade much more efficiently than E-cadherin expressing (Ecad+) cells. Ncad+ MCAs exhibit 
rapid lateral dispersal prior to penetration of three-dimensional collagen matrices. When seeded as 
individual cells, lateral migration and cell-cell junction formation precede matrix invasion. 
Neutralizing the Ncad extracellular domain with the monoclonal antibody GC-4 suppresses lateral 
dispersal and cell penetration of collagen gels. In contrast, use of a broad spectrum matrix 
metalloproteinase (MMP) inhibitor (GM6001) to block endogenous membrane type 1 matrix 
metalloproteinase (MT1-MMP) activity does not fully inhibit cell invasion. Using intact tissue 
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explants, Ncad+ MCAs were also shown to efficiently rupture peritoneal mesothelial cells, 
exposing the sub-mesothelial collagen matrix. Acquisition of Ncad by E-cadherin expressing cells 
(Ecad+) increased mesothelial clearance activity, but was not sufficient to induce matrix invasion. 
Furthermore, co-culture of Ncad+ with Ecad+ cells did not promote a “leader-follower” mode of 
collective cell invasion, demonstrating that matrix remodeling and creation of invasive micro-
tracks are not sufficient for cell penetration of collagen matrices in the absence of Ncad. 
Collectively, our data emphasize the role of Ncad in intraperitoneal seeding of EOC and provide 
the rationale for future studies targeting Ncad+ in pre-clinical models of EOC metastasis.
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INTRODUCTION
Epithelial ovarian carcinoma (EOC) is the leading cause of death among all female 
reproductive cancers, with a predicted 14 240 deaths estimated in the US in 2016 (1). In the 
overwhelming majority of cases, tumors are detected at a late stage when metastatic disease 
is already present, resulting in poor prognosis (2). Moreover, most patients with good initial 
response to chemotherapy eventually exhibit drug resistance and relapse (3). Therefore a 
detailed molecular-level understanding of the mechanisms involved in the acquisition of 
aggressive metastatic disease is needed to develop novel therapeutic approaches to prevent 
metastatic dissemination and improve long-term survival of women with ovarian cancer.
Ovarian tumors are thought to arise from the ovarian surface epithelium as well as the distal 
fimbriae of the fallopian tubes, from which shed cells implant on the ovarian surface (4–7). 
Unlike most solid tumors, EOC metastasis occurs by shedding of cancer cells from the 
ovarian tumor directly into the peritoneal cavity as both single cells and multicellular 
aggregates (MCAs) that disseminate with the peritoneal fluid flow (5,7). Hematogenous 
metastasis with homing to the peritoneal cavity has also been described (8,9). These 
anchorage-independent cancer cells subsequently adhere to peritoneal mesothelial cells, 
induce rapid mesothelial cell retraction (10,11), and invade the sub-mesothelial interstitial 
collagen-rich extracellular matrix (ECM) wherein they proliferate to form widely 
disseminated metastatic lesions on the peritoneum, omentum, and bowel (7). The MCA as a 
metastatic unit is poorly understood. It has been demonstrated that individual cells as well as 
MCAs from malignant primary human ovarian cancer ascites adhere to and dissociate upon 
both collagen and human mesothelial cell monolayers in vitro (12). However, the majority of 
these MCAs fail to invade, suggesting heterogeneity in the MCA population that may 
influence metastatic success (13).
Most experimental studies of matrix invasion utilize dissociated suspensions of cells and 
have implicated multiple molecular events in the invasive process. For example, the ability 
to overcome steric hindrance imposed by ‘pores’ within matrices that are smaller than 
invading cells is related to a complex combination of cell adhesiveness, nuclear volume, cell 
contractility and matrix stiffness (14). Invasion is also facilitated by expression of matrix 
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degrading metalloproteinases that remove physical constraints on cellular migration (15–20). 
However the role of cadherin-mediated cell-cell adhesion, particularly in MCA invasion, 
remains unclear. Cadherins are calcium-dependent cell-cell adhesion molecules that function 
to maintain epithelial integrity. While fallopian tube epithelia express epithelial cadherin 
(Ecad) (21,22), the mesodermally derived ovarian surface epithelium expresses neural 
cadherin (Ncad) (4,23). We have previously shown that approximately 30% of human 
ovarian tumors exhibit simultaneous positive immunoreactivity for both Ecad and Ncad with 
two predominant expression patterns (5,24). Tumors exhibit ‘mixed’ cadherin expression, 
wherein distinct cells within one tumor express either Ecad or Ncad, as well as ‘hybrid’ 
cadherin expression, characterized by Ecad and Ncad expression in the same cell (24). 
Furthermore, in a paired analysis of primary and metastatic ovarian tumors from the same 
patient, Ncad immunoreactivity was maintained in ~70% of metastases while only 25% 
retained Ecad expression (5). Therefore, to evaluate cellular activities associated with 
metastatic success in the context of cellular ultrastructure (individual cells vs MCAs) and 
cadherin expression profile, we used live imaging and electron microscopy to quantify 
interaction with intact peritoneal explants, organotypic meso-mimetic cultures and three-
dimensional (3D) interstitial collagen gels to model sub-mesothelial anchoring of EOC cells 
in the peritoneum.
RESULTS
The peritoneum, which lines the peritoneal cavity and covers all the abdominal organs, is the 
initial point of contact for disseminating EOC cells and MCAs during metastatic 
progression. Underlying the mesothelial monolayer, the sub-mesothelial matrix displays 
highly organized loosely woven collagen fibers in tumor-free animals, as observed using 
second harmonic generation (SHG) imaging of intact peritoneal explants [Fig. 1A]. Using a 
murine allograft model of EOC metastasis, we observe widely disseminated intraperitoneal 
seeding by cells and cell clusters, with subsequent penetration of the collagen-rich sub-
mesothelial matrix [Fig. 1B–E]. Cellular invasion is accompanied by significant deformation 
of the surrounding collagen matrix, resulting in loss of the highly organized parallel collagen 
fiber orientation seen in tumor-free animals, as well as the appearance of collagen-free areas 
[Fig. 1B] continuing into micro-tracks as observed by combined fluorescence/SHG imaging 
of peritoneal explants [Fig. 1C–E; Suppl. Movie 1–2].
Penetration of 3D collagen gels by EOC cells and MCAs is cadherin-dependent
To model EOC sub-mesothelial collagen invasion and anchoring and to address the role of 
the cadherin expression repertoire in these processes [Suppl. Fig. 1], we performed 
continuous live imaging of Ecad+ and Ncad+ EOC cells and MCAs. OvCa433 cells (Ecad+) 
tagged with red fluorescent protein (RFP) and DOV13 cells (Ncad+) expressing green 
fluorescent protein were seeded as individual cells or MCAs onto 3D collagen gels and 
continuously traced with a laser scanning confocal microscope in reflectance mode for 
matrix imaging and fluorescence mode for cell visualization [Fig. 2A]. Quantitation of the 
depth of penetration of individual cells revealed that both Ncad+ and Ecad+ cells remain 
relatively superficially localized, penetrating the collagen gel to a depth equivalent to one 
cell diameter (12–15 μm for DOV13, and 20-30μm for OvCa433) [Fig. 2B, C–D]. Relative 
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to individual cells, MCAs showed distinctly different patterns of dispersal on collagen gels. 
Ecad+ MCAs exhibited moderate aggregate dissociation on the collagen gel surface and 
invasion of the lower cell layer to a depth comparable to that observed with individual cells 
[Fig. 2B, E]. In contrast, Ncad+ MCAs underwent rapid lateral dispersal by 24h, followed 
by significant penetration of the collagen gel [Fig. 2B, F]. Ncad+ MCAs also displayed 
considerable lateral motility (8.8±1.8 μm/h), rapidly contacting neighboring aggregates and 
fusing into super-aggregates within 4–8h [Fig. 3]. Ecad+ MCAs were less motile (7.0±1.4 
μm/h) and aggregate fusion was not visible prior to ~30h [Fig. 3]. Peri-cellular collagen 
clearance was also enhanced in MCAs relative to individual cells [Suppl. Fig. 2A, B]. This is 
not due to mechanical deformation of the matrix, as control experiments using fluorescent 
beads (31μm diameter) showed no signs of lateral motility, collagen penetration or collagen 
clearance [Fig. 2B; Suppl. Fig. 3]. Interestingly, at longer incubation times, individual Ncad
+ cells establish a cell-cell contact network that then initiates collagen gel penetration while 
retaining cellular contacts [Fig. 4A, B]. This is consistent with the multicellular streaming 
invasion phenotype characteristic of mesenchymal cells, wherein cells retain tip-like cell:cell 
contacts [Fig. 4B, arrows; (25–27)]. Similar tip-like junctions were observed between ID8 
cells (Ncad+; [Suppl. Fig. 1A]) invading intra-peritoneal collagen in vivo [Suppl. Fig. 4, 
arrows]. This behavior was not observed in Ecad+ cells and MCAs, even when incubated for 
>7d (data not shown).
Contribution of Ncad expression and MMP activity to collagen invasion
Matrix proteolysis can facilitate matrix remodeling and cell migration through tissue 
barriers. The membrane-anchored interstitial collagenase membrane type 1 matrix 
metalloproteinase (MT1-MMP) is overexpressed in EOC (19,28,29) and has been shown to 
process collagen fibers, creating tube-like micro-tracks for invading cells (15,16). To 
differentiate the functional effect of a gain of MT1-MMP or Ncad expression on collagen 
invasion, we evaluated two genetically modified subclones of OvCa433 (Ecad+) cells: 
OvCa433Ncad+ cells, that express Ncad in addition to endogenous Ecad (24) and OvCa433-
MT cells, that express catalytically active MT1-MMP (30). Examination of cells and MCAs 
showed that neither OvCa433-MT [Fig. 5A–B, E] nor OvCa433Ncad+ [Fig. 5C–D, E] 
gained the ability to invade collagen gels. Of note, both clones had a smaller spherical cell 
diameter (18.9±3.2μm and 18.0±3.0 μm for OvCa433-MT and OvCa433Ncad+ vs 
22.9±4.3μm for OvCa433), resulting in an overall lesser penetration depth relative to 
parental OvCa433 cells [Fig. 5E]. At 72 hours of incubation an occasional cell migrated 
from OvCa433Ncad+ MCAs, but did not penetrate deeply [Fig. 5F], possibly due to polarity 
cues from Ecad (31). In this context, it is interesting to note that the murine EOC cell line 
ID8 expresses Ncad and lacks MT1-MMP, yet penetrates intra-peritoneal collagen in vivo 
[Fig. 1; Suppl. Fig. 1A; Suppl. Fig. 4].
To further examine the role of Ncad-mediated cell-cell communication in collagen invasion, 
function blocking antibodies (GC-4) or isotype control IgG were used to inhibit Ncad 
junctional activity. Blocking Ncad function with GC-4 resulted in a significant delay in 
lateral dispersal atop the gel and retarded de novo cell-cell junction formation compared to 
controls [Fig. 6A]. Subsequently, GC-4-treated cells exhibited a 3.4-fold reduction in depth 
of penetration. Occasional cell invasion was observed, but only after 7d of incubation [Fig. 
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6B]. MT1-MMP levels were not altered by GC-4 treatment [Suppl. Fig. 5]. Interestingly, 
previous studies have highlighted the importance of blocking Ncad to inhibit collective 
migration of cell clusters in 3D matrices, and predicted a lack of impact against single cell 
invasion [38]. However, data in the current study show that individual cells engage in lateral 
motility and adherens junction formation prior to collagen invasion, and Ncad-neutralizing 
antibody successfully blocked EOC network formation and subsequent cell invasion through 
3D collagen matrices.
To elucidate the contribution of MT1-MMP-driven matrix remodeling to the invasive activity 
observed in DOV13 cells, the broad-spectrum MMP inhibitor GM6001 was used. DOV13 
cells or MCAs were pre-incubated with GM6001 and inhibitor was replenished every 24h 
throughout the experiment (72h). Although inhibition of MT1-MMP activity significantly 
blocked collagen remodeling by both cells and MCAs [Fig. 7A, B], this treatment mitigated, 
but did not completely block, matrix invasion by cancer cells [Fig. 7A, C; Suppl. Fig. 5].
Lack of collective cell behavior in co-cultured epithelial and mesenchymal cells
Recent reports describe the occurrence of collective cell behavior in co-cultured cells, 
wherein invasive mesenchymal (Ncad+) cells (“invading leaders”) generate micro-tracks that 
facilitate the movement of non-invasive Ecad-expressing cells (“followers”) through the 
existing tracks (32,33). For example, formation of Ecad-Ncad junctions between highly 
invasive Ncad+ breast or prostate cancer cells and non-invasive Ecad-expressing cells 
derived from normal mammary or normal prostate epithelium, respectively, was reported 
with subsequent “leader-follower” invasive behavior (33). A related study demonstrated 
collective invasion initiated by invasive fibroblasts and followed by non-invasive squamous 
cell carcinoma cells (32). As heterogeneous cadherin expression patterns are observed in 
ovarian tumors, with many human EOC tumors containing both Ecad- and Ncad-expressing 
cells, (5,24), we sought to determine whether invasive mesenchymal cells create micro-
tracks in collagen that may serve as a conduit for less invasive cells. Mixtures of invasive 
Ncad+ DOV13 and non-invasive Ecad+ OvCa433 cells were seeded onto 3D collagen gels 
and observed by live imaging [Fig. 8]. At earlier time points (24–48h), cells sorted laterally 
into distinct superficial networks based on cadherin composition [Fig. 8A]. Subsequent 
collagen invasion was observed only by Ncad+ DOV13 cells, while Ecad+ OvCa433 cells 
remained superficially localized and did not invade through pre-formed micro-tracks [Fig. 
8A,B; Suppl. Movie 3]. After 14d of incubation, DOV13 cells completely penetrated and 
degraded most of the matrix, while non-invasive OvCa433 cells have dissociated from one 
another and undergone cell death [Fig. 8C; Suppl. Movie 4].
Cadherin composition impacts mesothelial clearance in vitro and ex vivo
To access the sub-mesothelial collagen matrix and effectively establish secondary lesions, 
EOC cells and MCAs initially contact the peritoneal mesothelium, a monolayer of cells 
lining the peritoneal cavity which serves as barrier for tumor cell penetration. Using intact ex 
vivo peritoneal tissue explants, we observed that individual Ncad+ DOV13 cells avidly 
adhere to mesothelial cells and extrude cellular processes between mesothelial junctions 
within 2h of cell seeding [Fig. 9A], but did not disrupt the mesothelial monolayer. In striking 
contrast, lateral dissociation of DOV13 MCAs [Fig. 9B] induces substantial disruption to 
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and clearance of the mesothelial cell monolayer, accompanied by mesothelial cell rupture 
within 4h of MCA seeding, as evidenced by disintegration of the mesothelial cell membrane 
and exposure of the cytoskeleton [Fig. 9Bd]. To further examine the role of Ncad in 
mesothelial cell clearance activity, a quantitative in vitro assay was used (34) wherein cells 
were seeded atop a fluorescently tagged confluent mesothelial cell layer in meso-mimetic 
cultures (35). Similar to results observed with ex vivo intact tissue explants, DOV13 MCAs 
seeded atop a mesothelial cell monolayer quickly attached, migrated through the 
mesothelium within the first 24h and dispersed on the culture dish underneath mesothelial 
cells by 72h of incubation [Fig. 9C, F; Suppl. Fig. 6]. Ecad+ OvCa433 MCAs adhered to the 
mesothelium, but demonstrated minimal mesothelial clearance by 72h [Fig. 9D, F]. However 
acquisition of Ncad expression (OvCa433Ncad+) significantly increased the rate of 
mesothelial clearance after 24–48h [Fig. 9E, F].
DISCUSSION
Metastatic dissemination of EOC is largely mediated by direct extension of cells into the 
peritoneal cavity, wherein they survive suspended in ascites fluid as individual cells and 
MCAs that subsequently adhere to peritoneal mesothelial cells, induce mesothelial cell 
retraction and penetrate the underlying 3D collagen matrix to establish secondary lesions 
(5,7,10,11). Human ascites-derived cells and MCAs exhibit a range of adhesive behaviors, 
suggesting that specific cellular phenotypes dictate metastatic propensity. Using multiple in 
vitro, ex vivo and organotypic cultures to model events in EOC metastasis, results from the 
current study show that both Ncad expression and MMP-mediated proteolysis are key 
determinants driving mesothelial clearance and matrix invasion by EOC cells, thus 
characterizing the aggressive phenotype. Importantly, blocking Ncad adhesion complexes 
and MMP-mediated matrix proteolysis significantly reduced mesothelial clearance ability 
and collagen invasion.
Experiments using live cell fluorescence microscopy to visualize movement through 3D 
collagen matrices by individual cells and MCAs with differentially expressed cadherins 
showed that only Ncad+ EOC cells and clusters effectively penetrate the collagen matrix and 
that this process is dependent upon Ncad-mediated junctional integrity. These results support 
the concept of collective cell behavior, which simultaneously integrates motility with matrix 
remodeling, and has been observed in normal morphogenesis as well as in cancer 
progression (25,26,36–41). Even when seeded at low density, Ncad+ cells migrate laterally 
prior to penetration of the collagen gel, wherein they retain loose ‘tip-like’ cell-cell junctions 
that involve only a fraction of the cell surface. Our in vivo results with ID8 cells (Ncad+) 
show that cells invading collagen-rich intra-peritoneal tissue also retain tip-like junctions. 
Similar morphological variants of collective migration were found in mesenchymal type 
tumors with conserved Ncad adherens junctions (26,38,40) and were histologically detected 
in in vivo studies of invasive epithelial cancer (42,43) and melanoma (44,45). Consistent 
with the current data, retention of Ecad expression is not associated with multicellular 
streaming (25,38). It is interesting to note that this is observed even in cells with the hybrid 
(dual cadherin) phenotype (24), suggesting that even low level Ecad expression provides 
morphological cues that modulate the collagen invasive phenotype. Based on these data, 
Ncad+ MCAs in ascites are predicted to more efficiently seed metastatic lesions due to the 
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presence of pre-formed Ncad cell-cell junctions. This prediction is supported in pre-clinical 
murine models of EOC, wherein Ecad+ cells such as OvCa433 grow subcutaneously but do 
not seed intraperitoneal xenografts (data not shown and (46,47)) while Ncad+ lines 
including human DOV13, SKOV3ip, and OVCAR8 as well as murine ID8 cells readily 
anchor and proliferate, forming widely disseminated peritoneal implants (48–50). 
Furthermore, this observation is consistent with clinical data comparing primary tumors to 
metastatic lesions obtained from the same patient, showing prevalence of Ncad+ metastases 
(5).
In addition to Ncad, invasion of collagen matrices is also impacted by MMP expression. 
EOCs express the interstitial collagenase MT1-MMP (15–19), and expression is enhanced in 
peritoneal metastases relative to paired primary tumors (19). In this study, Ncad+ DOV13 
cells also endogenously express MT1-MMP, which catalyzes collagenolysis as well as 
matrix reorganization to facilitate movement of migrating cancer cells (15,17,51). It is 
interesting to note that MT1-MMP mRNA and protein levels are upregulated in MCA 
cultures (30), consistent with our current results that show enhanced collagen remodeling by 
MCAs. Nevertheless, inhibition of MMP activity with the broad spectrum small molecule 
GM6001 significantly decreased collagen peri-cellular collagen clearance, but only partially 
suppressed collagen matrix invasion by both individual cells and MCAs. It was recently 
shown that MT1-MMP-mediated proteolysis is critical for “leader-follower” behavior in 
heterotypic co-cultures of non-invasive normal breast epithelial MCF-10A cells and 
malignant MDA-MB-231 breast cancer cells. MCF-10A cells were shown to “follow” the 
MDA-MB-231 “leader” cells through invasive strands in collagen gels, and addition of 
GM6001 abolished this behavior (33). This is in contrast to our co-culture experiments, 
wherein non-invasive Ecad+ OvCa433 cells segregated away from invasive Ncad+ DOV13 
cells and did not “follow” tracks formed by DOV13 cells through the collagen gel. Together 
these data suggest that MT1-MMP dependent proteolysis and collagen reorganization are 
not wholly sufficient for metastatic anchoring in sub-mesothelial collagen in peritoneal 
metastases. This is consistent with our in vivo data using ID8 (Ncad+) cells that invade intra-
peritoneally but do not express MT1-MMP, and suggest that factors in addition to MMP 
activity contribute to invasion.
Prior to engaging collagen, metastasizing EOC cells first encounter the mesothelial 
monolayer that lines the peritoneal cavity. Consistent with previous findings (52), our results 
show that Ncad+ MCAs exhibit enhanced mesothelial clearance relative to Ecad+ 
aggregates. Furthermore, acquisition of Ncad augments this process, even in hybrid Ecad/
Ncad-expressing cells. Contrary to previous studies, however, our results using intact 
peritoneal tissue explants reveal a distinct fate for peritoneal mesothelial cells. While in vitro 
studies of mesothelial clearance suggest temporary disassembly of mesothelial layers (11), 
our ex vivo data indicate that EOC MCAs physically rupture the underlying mesothelial 
cells, leading to a permanently compromised mesothelial monolayer with exposed sub-
mesothelial collagen that provides an adhesive substratum to which EOC cells avidly adhere 
(19,53).
Our results using Ncad function blocking antibodies show delayed lateral dispersal and 
reduced collagen gel penetration relative to IgG-treated controls. While the underlying 
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mechanism requires further investigation, it is interesting to speculate that the GC-4 
antibody may alter cell-matrix mechanosensing through the HAVDI adhesive site in the 
Ncad EC1 ectodomain. HAVDI ligation alters signaling via the YAP/TAZ complex, known 
to be an important factor in the transduction of mechanical signals (54,55). Furthermore, 
HAVDI ligation attenuates YAP/TAZ cellular mechanosensing, reducing myosin IIA 
accumulation in focal adhesions and thereby decreasing traction force generation, cell 
contraction, motility and invasion (56,57). Additionally, collective cancer cell invasion may 
involve mechanotransduction at adherens junctions, triggering β-catenin recruitment and 
adhesion reinforcement, which may be particularly important when heterotypic junctions are 
formed (58). Alternatively, binding of GC-4 to Ncad may inhibit the cis interaction between 
Ncad and the fibroblast growth factor (FGF) receptor. This interaction has been shown to 
regulate FGF receptor dimerization and activation of signal transduction pathways, thereby 
promoting cell motility (59–62). Further studies are needed to probe the precise contribution 
of Ncad and its binding partners to mechanisms of EOC invasion.
Pre-clinical studies have been reported using several distinct Ncad antagonists including 
linear and cyclic peptides that harbor the HAV cell adhesion recognition motif (63,64) as 
well as function-blocking antibodies. For example, the pentapeptide ADH-1 (Exherin™, 
Adherex Technologies Inc., Durham, NC) is currently under active investigation in 
preclinical and clinical trials based on its ability to induce tumor cell apoptosis and disrupt 
vasculature (63–68). However, the very short half-life (~2.2h for Exherin (69)) is a drawback 
of this class of therapeutic agents for usage in vivo as it would require continuous 
intraperitoneal delivery of the drug. A recently reported linear peptide antagonist of Ncad, 
harboring a Trp residue in the second position (65,70), has been used in vitro to block 
aggregation of beads coated with the Ncad ectodomain and to inhibit endothelial cell tube 
formation; however its effect on tumor cell interaction with tissues and matrices has not been 
evaluated. Monoclonal antibodies against Ncad have been shown to inhibit heterotypic 
adhesion between Ncad+ invasive breast cancer cells and mammary stromal cells (71), to 
repress adhesion, invasion and proliferation of prostate cancer cells in vitro, and to mitigate 
prostate cancer xenograft growth and metastasis in vivo (72). Collectively, our findings 
delineate the importance of Ncad expression for effective peritoneal seeding by 
metastasizing EOC cells and provide the rationale to support future pre-clinical studies using 
intraperitoneal delivery of Ncad blocking molecules as a therapeutic strategy to suppress 
EOC metastatic anchoring.
MATERIALS AND METHODS
Cell Lines
The EOC cell lines OvCa433 and DOV13 were kindly provided by Dr. Robert Bast (M.D. 
Anderson Cancer Center, Houston, TX). Cells were maintained in Minimal Essential 
Medium (MEM; Gibco, Big Cabin, OK) containing 10% Fetal Bovine Serum (FBS; Gibco), 
1% Non-Essential Amino Acids (Corning Cellgro, Manassas, VA), 1% Penicillin/
Streptomycin (Lonza, Allendale, NJ), 1% Sodium Pyruvate (Corning Cellgro), 0.1% 
Amphotericin B (Cellgro), and supplemented with 10μg/ml Insulin (Gibco) for DOV13 cell 
medium only. The human peritoneal mesothelial cell line LP9 was obtained from Coriell 
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NIA Aging Cell Repository (Camden, NJ) and maintained in a 1:1 ratio of M199 and Ham 
F12 media (Gibco), supplemented with 15% FBS, 1% Penicillin/Streptomycin, 1% HEPES 
(Gibco), 1% GlutaMAX (Gibco), 10ng/ml epidermal growth factor (EGF; Sigma, St Louis, 
MO), 400ng/ml hydrocortisone (Sigma). ID8 murine EOC cells were obtained from Dr. 
Katherine Roby (University of Kansas Medical Center, Kansas City, KS). Cells were 
maintained in Dulbecco’s Modification of Eagle’s Medium (DMEM; Corning Cellgro) 
containing 4% FBS, 1% Penicillin/Streptomycin, and supplemented by 5 μg/mL Insulin, 5 
μg/mL Transferrin, and 5 ng/mL Sodium Selenite (1% ITS; Sigma). Cell lines were tested 
and authenticated by Genetica DNA Laboratories using short tandem repeat (STR) DNA 
profiling and were found to be >95% concordant. Cells tested negative for mycoplasma in 
2015. Generation of stable OvCa433Ncad+ (OvCa433 that express N-cadherin in addition to 
endogenous E-cadherin) and OvCa433MT (OvCa433 that express catalytically active MT1-
MMP) cell lines has been described previously (24,30). Transfected cells were maintained in 
medium supplemented with Geneticin (600μg/ml; Enzo Life Sciences, Farmingdale, NY) 
and routinely sorted every five passages on a BD FACSAria III cell sorter to ensure 
continuous protein expression.
RFP lentiviral vector (GenTarget, San Diego, CA) was used to generate fluorescently tagged 
OvCa433-RFP and LP9-RFP cell lines. GFP lentiviral vector (AddGene, Cambridge, MA) 
was utilized to create DOV13-GFP and LP9-GFP stable cell lines. Lentiviral transductions 
were performed according to manufacturers’ protocols and successfully tagged cells were 
further selected via BD FACSAria III cell sorter. Generation of fluorescently labeled ID8-
RFP cell line has been previously described (49). Short-term fluorescent labeling of cells 
was performed as described (24,30).
Fluorescence/SHG Imaging of Murine Metastatic Lesions
Female C57Bl/6 mice (Mus musculus) of varying ages (6–22mo) (n=12, Jackson 
Laboratories, Bar Harbor, ME) were injected intraperitoneally with 1–10×106 ID8-RFP 
murine EOC cells as previously described (49). Normal collagen was also examined in 
tumor free mice (n=30) as a component of a larger study. No randomization method was 
used. Animal procedures were carried out according to the regulations of the University of 
Notre Dame Animal Care and Use Committee. Mice were sacrificed by CO2 inhalation 
followed by cervical dislocation at 8–10 weeks post-injection. The parietal peritoneum was 
dissected, rinsed with PBS and placed between coverslips for imaging with the mesothelium 
side facing the objective (25X XLPlanN, 1.05na WATER) of the 2-Photon confocal 
microscope (Olympus FV1000, software FLUOVIEW FV1000). Using a Mai Tai DeepSee 
titanium-sapphire 690–1040nm laser, ID8 metastatic implants and peritoneal collagen were 
visualized by the RFP and SHG signals, respectively. The investigator was not blinded 
during animal study. Areas of peritoneum with collagen-tumor interactions present were 
specifically imaged. At 12% laser power, the 2-photon laser was set to 860 nm and emission 
was simultaneously collected at 425–465 nm and 575–625 nm for SHG and RFP, 
respectively.
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MCA Formation via Hanging Drop Method
EOC cells were harvested, centrifuged and re-suspended in fresh medium at 5,000 cells/ml. 
Droplets (20μl) were seeded on inner surface of a 150 × 25 mm tissue culture dish lid (100 
cells/droplet). PBS was added to the lower dish and the lid was gently inverted atop the dish. 
Cells were incubated at 37°C for 48 hours and MCA formation was confirmed by light 
microscopy.
Invasion of 3D collagen gels
3D collagen gels were constructed by diluting Rat Tail Collagen Type I (RTCI; BD 
Biosciences, San Jose, CA) with the corresponding complete cell medium to a 1.5mg/ml 
final concentration. This mixture (200ul) was placed into 20 mm glass wells of glass-bottom 
35mm dishes (#D35-20-1-N, In Vitro Scientific, Mountain View, CA) and incubated at 37°C 
× 20–30 min until gel polymerization. For individual cell collagen invasion experiments, 
harvested cells were diluted to 50,000 cell/ml. For MCA collagen invasion experiments, 
MCAs (100cell/MCA) were collected from the dish lid after 48 hours of incubation into 15 
ml falcon tubes and centrifuged at 2,200 rpm × 2 min at 22°C and MCA pellets were diluted 
in 200 μl of fresh full medium. Single cell or MCA suspensions (200 μl) were applied to 
solidified 3D collagen gels and continuously monitored using Nikon A1R-MP confocal 
microscope in reflectance mode for collagen imaging and fluorescence mode for cell 
imaging as detailed below. In a control experiment 31 μm beads (Green Fluorescent Polymer 
Microspheres, 10% CV, Duke Scientific Corp., Palo Alto, CA) were used to exclude 
potential effects of mechanical stresses due to gravity on invasion and lateral motion. In 
some experiments, DOV13 cells were pre-incubated with mouse monoclonal anti-Ncad 
antibody GC-4 (Sigma-Aldrich, St Louis, MO) or mouse isotype control IgG (ThermoFisher 
Scientific, Waltham, MA) (200 μg/ml) for 1h at 37°C prior to the start of collagen invasion 
experiments and replenished every 12h. Similarly, DOV13 cells were incubated with the 
broad spectrum MMP inhibitor GM6001 (EMD Millipore, Billerica, MA) (25μM) for 24h 
prior to invasion experiments or during hanging drop MCA formation. Fresh inhibitor was 
added every 24 hours.
Imaging of cellular dynamics in collagen gels was performed using a Nikon A1R-MP laser 
confocal microscope with ApoLWD 40× WI lambda-S DIC N2 water immersion objective 
lens to obtain a series of high resolution 100 μm thick z-stacks taken at time zero, 
continuously for 8h and then every 24h for 7–14 days at multiple (3–5) sites. An Argonne 
laser with a 488-nm wavelength and helium-neon laser beam with 594-nm wavelength were 
utilized for fluorescence confocal and reflectance imaging of tagged cells and unlabeled 
collagen, respectively. The voxel size of the obtained z-stacks was 0.2076×0.2076×0.6896 
μm3. All cell invasion assays were performed using the microscope environmental chamber 
to maintain 37°C and 5% CO2.
Cell/MCA Peritoneal Adhesion and Ex Vivo Mesothelial Clearance
Cell/MCA adhesion to murine peritoneum and mesothelial clearance were assessed using ex 
vivo explants of intact peritoneal tissue (35,73). C57Bl/6 mice (Jackson Laboratories, Bar 
Harbor, ME) were dissected using a ventral midline incision; 4 peritoneal tissue pieces were 
removed and pinned to the bottom of 24-well dishes pre-coated with optically transparent 
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silicone using Sylgard 184 Silicone Elastomer Kit (Fisher, Waltham, MA). Cells (200,000 
cell/ml) or pre-formed MCAs (100cell/MCA) were applied atop murine peritoneal explants 
and incubated for 2 or 4h, as indicated. The assay was stopped with 3 × 3min ice-cold PBS 
washes and tissue explants were subjected to further SEM processing and imaging.
Scanning Electron Microscopy (SEM)
Murine peritoneal explants were fixed in a 2% Glutaraldehyde, 2% Paraformaldehyde in 
0.1M Cacodylate buffer pH 7.35 primary fixative solution overnight at 4°C, followed by 3 × 
20min washes in 0.1 Cacodylate buffer. Secondary processing was performed with 2% 
Osmium tetroxide in 0.1 Cacodylate buffer using a PELCO® EM Pro Microwave vacuum 
chamber. Samples were then washed with ultrapure water 3 × 5min, dehydrated in a series of 
increasing Ethanol concentrations (20%, 50%, 70%, 90%, 3 × 100%), followed by critical 
point drying using Tousimis-931 dryer, placed on carbon stubs, sputter coated with iridium, 
and examined under FEI-Magellan 400 field emission SEM. Electron micrograph false 
colorization was applied using Adobe Photoshop CC 2014 software.
MCA In Vitro Mesothelial Clearance
LP9-RFP or LP9-GFP human peritoneal mesothelial cells were grown on collagen coated 
(20ng/ml) glass surfaces to 100% confluence. DOV13-GFP, OvCa433-RFP or CMTPX-
stained OvCa433Ncad+ MCAs (100cell/MCA) were applied atop the mesothelial cell layers. 
Subsequent dispersal of cancer cells/MCAs and mesothelial clearance activity were 
monitored using Nikon A1R-MP confocal microscope at 0, 24, 48 and 72 hour time points.
Image Analysis
Nikon software (NIS-Elements AR Analysis) software was used to analyze cell-collagen 
invasion and mesothelial clearance by a) quantifying the penetration depth of cells/MCAs, 
their lateral motility, the degree of deformation of collagen matrices in the collected z-stacks 
and b) the mesothelial clearance area, respectively. The penetration depth of cells or MCAs 
was defined as the distance from the lowest point on the bottom portion of cell/MCA surface 
to the top of collagen matrix. Cell lateral motility was quantified in terms of the cell/MCA 
average displacement per unit time in a horizontal plane from 8-hour time lapse by tracking 
the centers of each cell. For this, the coordinates of the center of each cell/MCA rc (xc, yc) 
were first determined from the collected z-stack images for each time point and the average 
speed was calculated as <dc/δt>, where dc is the displacement during the time interval δt. 
The degree of collagen remodeling was calculated in terms of the volume of voids 
surrounding the cell/MCAs inside the collagen matrix using confocal z-stack images 
acquired over the incubation period of 72 hours. The voids volume per cell or cluster was 
calculated as the sum of the collagen excluding areas measured for each z-slice, multiplied 
by the distance between slices, and divided by the number of cells/MCAs in the analyzed z-
stack. Mesothelial clearance analysis in the confocal z-stack images in GFP and RFP 
channels was performed using NIS-Elements software by assessing the area cleared by EOC 
cells at the bottom of the LP9 layer. Fluorescence/SHG images of murine metastatic lesions 
were reconstructed and visualized using Fiji open source software.
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Statistical Analysis
For each type of assay, statistical analysis using 3–6 z-stacks of confocal/reflectance 
microscopy images for a single sample in parallel multiple sample measurements was 
conducted. All data are obtained from at least 3 independent measurements and are 
expressed in terms of mean ± S.D. Statistical significance (defined as p<0.05) was calculated 
using a two-sided Mann-Whitney U test.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Murine allograft model of ovarian cancer metastasis demonstrates peritoneal seeding 
by cancer cells/MCAs with subsequent penetration and remodeling of sub-mesothelial collagen
C57Bl/6 female mice were injected intraperitoneally with ID8-RFP murine EOC cells and 
sacrificed at 8–10 weeks post injection. The parietal peritoneum was dissected and prepared 
for combined fluorescence/SHG microscopy as described in Methods. Shown are examples 
of (A) tumor-free mouse peritoneal explant (collagen, grey) and (B) peritoneal explant 
(collagen, grey) containing a metastatic lesion (cancer cells, red) exhibiting collagen 
reorganization and peri-cellular collagen clearance areas (arrows). Scale bars: as indicated. 
Murine metastatic lesions depict (C) seeding of cancer cells and cell clusters (red) atop of 
peritoneal collagen layer (grey), (D) 3D volume view and (E) orthoslice view of cancer cells 
penetrating the sub-mesothelial collagen layer. Scale bars: as indicated.
Klymenko et al. Page 17
Oncogene. Author manuscript; available in PMC 2017 December 19.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. Cadherin composition impacts matrix invasion by EOC cells and MCAs
A) Overview of collagen invasion live imaging assay. EOC cells are fluorescently tagged 
with RFP or GFP via lentiviral transduction and applied as either individual cells or pre-
formed MCAs on top of a 3D collagen gel (1.5mg/ml collagen concentration in complete 
medium) inside a glass-bottom dish. Continuous z-stack imaging of cell/MCA dynamics 
(green or red) and collagen (blue) was performed using confocal fluorescence and 
reflectance modes, respectively. B–F) Imaging and analysis of collagen invasion. Multiple 
representative z-stack snapshots of (C) OvCa433-RFP (Ecad+) cells, (D) DOV13-GFP 
(Ncad+) cells, (E) OvCa433-RFP (Ecad+) MCAs, (F) DOV13-GFP MCAs, and (Suppl. fig. 
2) control fluorescent beads were obtained for up to 72h, and depth of penetration depth 
quantified (Mean±SD, N=100 in three assays);scale bar: 100μm. Statistical significance 
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shown between the penetration depth of each cell line relative to fluorescent beads; p<0.05, 
Mann-Whitney U test.
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Figure 3. EOC individual cells and MCAs exhibit distinct rates of lateral motility
DOV13-GFP (Ncad+) and OvCa433-RFP (Ecad+) individual cells or MCAs were applied 
on top of a 3D collagen gel construct (1.5mg/ml) inside a glass-bottom dish; 8-hour time-
lapse confocal imaging of cell/MCAs (green or red) and collagen matrix (blue) was 
performed in fluorescent and reflectance modes, respectively. A) Representative images of 
DOV13-GFP and OvCa433-RFP MCA dynamics are shown at stated time points (scale bars 
as indicated). B) Evaluation of lateral motility for different cell types (Mean±SD); all assays 
were repeated in triplicate; statistical significance shown between the lateral motilities of 
each cell line and fluorescent beads; p<0.05, Mann-Whitney U test.
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Figure 4. Lateral motility of mesenchymal-type Ncad+ cells creates an invasion-permissive 
cell:cell network
Individual DOV13 (Ncad+) cells were applied atop 3D collagen gels (1.5mg/ml) inside a 
glass-bottom dish, and series of z-stack confocal microscopy images were acquired using 
fluorescence and reflectance modes to visualize cells (green) and collagen (blue), 
respectively, during the course of incubation. A) Representative images demonstrate cellular 
network formation via tip-like cell:cell junctions (top view) and matrix invasion (3D view) 
by cancer cells after 7 days of incubation. Scale bar: 100μm. B) A magnified 3D volume 
view depicts cellular junctions between invading cells and adjacent superficially located 
cells (indicated by arrows). Scale bar: 50 μm.
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Figure 5. Acquisition of MT1-MMP or Ncad by Ecad+ EOC cells is not sufficient to induce 
matrix invasion
Ecad+ OvCa433MT1 and OvCa433Ncad+ cells were transiently stained with green CMFDA 
or red CMTPX CellTracker dyes, respectively, as described in Methods, applied atop 3D 
collagen gels (1.5mg/ml) inside a glass-bottom dish as individual cells (A and C) or MCAs 
(B and D), and imaged in confocal fluorescence (cancer cells, green or red) and reflectance 
(collagen, blue) modes over the course of incubation. Scale bars: 100μm. E) Matrix invasion 
by cells evaluated in terms of cell penetration depth changes with incubation time (M±SD, 
N=100 single cells and 30 MCAs of three assays). Statistical significance shown between 
the penetration depths of each cell type and passive beads; p<0.05, Mann-Whitney U test. F) 
Enlarged 3D view of OvCa433Ncad+ MCA dispersed on collagen after 72h of incubation is 
shown. Scale bar: 50μm.
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Figure 6. Blocking Ncad suppresses matrix invasion
A) Individual Ncad+ DOV13 cells were applied on top of a 3D collagen gel (1.5mg/ml) 
inside a glass-bottom dish, and incubated in the presence of Ncad-blocking antibody clone 
GC-4 (200μg/ml), isotype control IgG (200μg/ml), or no drug, as detailed in Methods. 
Representative reconstructed 3D images of cancer cells (green, fluorescence mode) and 
collagen matrix (blue, reflectance mode) acquired after 0h, 24h, 72h, and 7 days of 
incubation. Scale bar: 100μm. B) Evaluation of matrix invasion by EOC cells at different 
time points of incubation in terms of penetration depth changes (M±SD, N=100). Statistical 
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significance shown between the penetration depths of each cell type and passive beads; 
****p<0.0001, Mann-Whitney U test.
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Figure 7. Inhibition of MT1-MMP modulates matrix invasion and collagen remodeling by EOC 
cells
A) Individual Ncad+ DOV13 cells (that endogenously express MT1-MMP) were applied 
atop 3D collagen gels (1.5mg/ml) inside a glass-bottom dish, and incubated with the broad 
spectrum MMP inhibitor GM6001 (25μM) or with no inhibitor, as detailed in Methods. 
Nikon A1R-MP confocal microscope was used for continuous z-stack imaging of cancer 
cells (green, fluorescence mode) and collagen (blue, reflectance mode). Representative 
images at 72h incubation time point are shown. Scale bar: 100μm. Evaluation of (B) peri-
cellular collagen remodeling after 72hr of incubation, and (C) cell penetration depth at 24 
and 72h. All assays were repeated in triplicate and statistical analysis was performed using 
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Mann-Whitney U test. Statistical significance is shown for Ovca433MT1-MMP and 
OvCa433Ncad+ with respect to OvCa433 invasiveness.
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Figure 8. Cadherin-dependent sorting of EOC cells does not promote collective migration
Ncad+ DOV13 and Ecad+ OvCa433 cells were applied atop 3D collagen gels (1.5mg/ml) 
inside a glass-bottom dish, and series of z-stack confocal images were acquired to observe 
cell-cell and cell-collagen interactions up to 14 days of incubation. Fluorescent and 
reflectance confocal modes were utilized to image cells (red, green) and collagen matrix 
(blue), respectively. A) Representative images of sorting and homotypic network formation 
(top view) and collagen invasion (3D view) at stated time points. Scale bar: 100μm. B) 
Evaluation of penetration depth of cell populations (M±SD, N=100 of three assays). 
Statistical significance is shown between the penetration depths of each cell line type and 
passive beads; p<0.05, Mann-Whitney U test. C) A representative 3D volume view of 
cellular dynamics after 14 days of incubation. Scale bar: 100μm.
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Figure 9. Cadherin composition impacts mesothelial clearance in intact tissue explants and 
organotypic meso-mimetic cultures
(A–B) Ex vivo peritoneal adhesion and mesothelial clearance. Murine peritoneal tissue 
explants were dissected and pinned ‘mesothelium-side-up’ on optically clear silastic resin as 
described in Methods and incubated with (A) DOV13 cells (2h) or (B) DOV13 MCAs (4h). 
Explants were rinsed with ice-cold PBS 3 × 3 min, subjected to SEM processing and imaged 
with FEI-Magellan 400 field emission microscope (scale bars as indicated). For clarity of 
visualization, DOV13 cells (Ab–d) and MCAs (Bb–c) are pseudo-colored green while 
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ruptured mesothelial cells are pseudo-colored purple (Bb–d). The yellow dashed line in (Ba) 
depicts the borders of the dispersed MCA in the lower magnification image while the white 
rectangles identify areas magnified in (Bb) and (Bc), respectively. The white rectangle in 
panel (Bb) identifies the area of ruptured mesothelium magnified in (Bd). (C–E) Imaging of 
MCA mesothelial clearance using in vitro meso-mimetic cultures. (C) DOV13-GFP, (D) 
OvCa433-RFP or (E) CMTPX-stained OvCa433Ncad+ MCAs were applied on top of (C) 
RFP-tagged or (D–F) GFP-tagged LP9 mesothelial cell layers grown in 35mm glass-bottom 
dishes to 100% confluence, and subsequent MCA dispersal and mesothelial clearance 
activity (indicated by dotted line for DOV13 MCAs, visually detectable for OvCa433 and 
OvCa433Ncad+ MCAs) were observed using confocal microscopy during the course of 
incubation. (F) Mesothelial clearance was quantified in terms of the LP9 cell area cleared by 
the individual EOC MCAs for different incubation time points (M±SD, N=16); ***p<0.001, 
****p<0.0001, Mann-Whitney U test; statistical significance is shown between different cell 
types.
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